Surgeons completed the first successful implantations of the FineVision HP trifocal IOL in the U.S., according to a press release from BVI.
BVI chief commercial officer Andy Chang told Healio that the FineVision HP IOL was designed to support a high-contrast range of distance, intermediate and near vision under varying light conditions.
“The higher near add power is intentionally optimized to enhance fine-detail near tasks while preserving visual quality and continuity across the full range of vision, including in dim light,” he said.
The IOL received FDA approval in October 2025.
Five surgeons